Clinical Trial: A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07185009) titled 'A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis' on Sept. 15.

Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC).

Study details include:

The study duration may be up to 286 weeks including:

* 40-week Pivotal Maintenance Sub-Study

* 240-week Open-Label Extension (OLE) Sub-Study

* 45-day Follow-up Visit Note: For the participants who do not enroll into OLE S...